Antithrombotic Drug Therapy in Cardiovascular Disease Edited By Arman T. Askari

Status

Published

on 11 Jan 2010

Year of Creation

2009

Springer Science+Business Media

Registration Number

TX0007170950

on 11 Jan 2010

The U.S. Copyright record (Registration Number: TX0007170950) dated 11 Jan 2010, pertains to an electronic file (eService) titled "Antithrombotic Drug Therapy in Cardiovascular Disease Edited By Arman T. Askari" created in 2009. The copyright holder is Springer Science+Business Media, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Springer Science+Business Media.

Springer Science+Business Media

Application Details

Registration Number

TX0007170950

Registration Date

1/11/2010

Year of Creation

2009

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

Springer Science+Business Media

Physical Description

Book, 475p

First Publication Nation

United States

ISBN

978-1-60327-234-6

Corporate Authors

Springer Science+Business Media

Statements

Application Title Statement: Antithrombotic Drug Therapy in Cardiovascular Disease Edited By Arman T. Askari

Author Statement: Springer Science+Business Media employer for hire Domicile: United States Authorship: text, editing

Statements

Application Title Statement: Antithrombotic Drug Therapy in Cardiovascular Disease Edited By Arman T. Askari

Author Statement: Springer Science+Business Media employer for hire Domicile: United States Authorship: text, editing

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.